Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats. (Q51563846)

7 April 2018

title

Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats. (English)

1 reference

7 April 2018

1 reference

Kosegawa I

1

1 reference

7 April 2018

Chen S

2

1 reference

7 April 2018

Awata T

3

1 reference

7 April 2018

Negishi K

4

1 reference

7 April 2018

Katayama S

5

1 reference

7 April 2018

publication date

1 April 1999

1 reference

7 April 2018

Clinical and Experimental Hypertension

published in

1 reference

7 April 2018

volume

21

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

199-211

1 reference

7 April 2018

Pathogenesis of NIDDM. A balanced overview

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Molecular physiology and genetics of NIDDM. Importance of metabolic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Insulin and blood pressure in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Antihypertensive effects of CS-045 treatment in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Effects of ciglitazone on blood pressure and intracellular calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641969909068661

10.3109/10641969909068661

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10225476

1 reference

7 April 2018